125 related articles for article (PubMed ID: 10843525)
41. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
42. Genital tract leukocytes and shedding of genital HIV type 1 RNA.
Anderson BL; Wang CC; Delong AK; Liu T; Kojic EM; Kurpewski J; Ingersoll J; Mayer K; Caliendo AM; Cu-Uvin S
Clin Infect Dis; 2008 Nov; 47(9):1216-21. PubMed ID: 18808359
[TBL] [Abstract][Full Text] [Related]
43. Genital self-sampling compared with cervicovaginal lavage for the diagnosis of female genital schistosomiasis in Zambian women: The BILHIV study.
Sturt AS; Webb EL; Phiri CR; Mweene T; Chola N; van Dam GJ; Corstjens PLAM; Wessels E; Stothard JR; Hayes R; Ayles H; Hansingo I; van Lieshout L; Bustinduy AL
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008337. PubMed ID: 32663222
[TBL] [Abstract][Full Text] [Related]
44. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women.
Spear GT; al-Harthi L; Sha B; Saarloos MN; Hayden M; Massad LS; Benson C; Roebuck KA; Glick NR; Landay A
AIDS; 1997 Sep; 11(11):1319-26. PubMed ID: 9302440
[TBL] [Abstract][Full Text] [Related]
45. HIV-1 outcompetes HIV-2 in dually infected Senegalese individuals with low CD4⁺ cell counts.
Raugi DN; Gottlieb GS; Sow PS; Toure M; Sall F; Gaye A; N'doye I; Kiviat NB; Hawes SE;
AIDS; 2013 Sep; 27(15):2441-50. PubMed ID: 23665777
[TBL] [Abstract][Full Text] [Related]
46. Human immunodeficiency virus type 1 RNA shedding in the female genital tract.
Goulston C; McFarland W; Katzenstein D
J Infect Dis; 1998 Apr; 177(4):1100-3. PubMed ID: 9534992
[TBL] [Abstract][Full Text] [Related]
47. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load.
Cu-Uvin S; DeLong AK; Venkatesh KK; Hogan JW; Ingersoll J; Kurpewski J; De Pasquale MP; D'Aquila R; Caliendo AM
AIDS; 2010 Oct; 24(16):2489-97. PubMed ID: 20736815
[TBL] [Abstract][Full Text] [Related]
48. Selective impact of HIV disease progression on the innate immune system in the human female reproductive tract.
Lahey T; Ghosh M; Fahey JV; Shen Z; Mukura LR; Song Y; Cu-Uvin S; Mayer KH; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
PLoS One; 2012; 7(6):e38100. PubMed ID: 22675510
[TBL] [Abstract][Full Text] [Related]
49. Residual HIV-1 RNA and HIV-1 DNA production in the genital tract reservoir of women treated with HAART: the prospective ANRS EP24 GYNODYN study.
Launay O; Tod M; Tschöpe I; Si-Mohamed A; Bélarbi L; Charpentier C; Goujard C; Taburet AM; Lortholary O; Leroy V; Bélec L;
Antivir Ther; 2011; 16(6):843-52. PubMed ID: 21900716
[TBL] [Abstract][Full Text] [Related]
50. Quantitation of HIV-1-specific IgG, IgA, and IgM antibodies in human genital tract secretions.
Haimovici F; Mayer KH; Anderson DJ
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jul; 15(3):185-91. PubMed ID: 9257652
[TBL] [Abstract][Full Text] [Related]
51. Correlation between human immunodeficiency virus type 1 RNA levels in the female genital tract and immune activation associated with ulceration of the cervix.
Lawn SD; Subbarao S; Wright TC; Evans-Strickfaden T; Ellerbrock TV; Lennox JL; Butera ST; Hart CE
J Infect Dis; 2000 Jun; 181(6):1950-6. PubMed ID: 10837174
[TBL] [Abstract][Full Text] [Related]
52. Initiation of antiretroviral therapy leads to a rapid decline in cervical and vaginal HIV-1 shedding.
Graham SM; Holte SE; Peshu NM; Richardson BA; Panteleeff DD; Jaoko WG; Ndinya-Achola JO; Mandaliya KN; Overbaugh JM; McClelland RS
AIDS; 2007 Feb; 21(4):501-7. PubMed ID: 17301569
[TBL] [Abstract][Full Text] [Related]
53. Genital tract inflammation during early HIV-1 infection predicts higher plasma viral load set point in women.
Roberts L; Passmore JA; Mlisana K; Williamson C; Little F; Bebell LM; Walzl G; Abrahams MR; Woodman Z; Abdool Karim Q; Abdool Karim SS
J Infect Dis; 2012 Jan; 205(2):194-203. PubMed ID: 22190580
[TBL] [Abstract][Full Text] [Related]
54. Anti-HIV activity in cervical-vaginal secretions from HIV-positive and -negative women correlate with innate antimicrobial levels and IgG antibodies.
Ghosh M; Fahey JV; Shen Z; Lahey T; Cu-Uvin S; Wu Z; Mayer K; Wright PF; Kappes JC; Ochsenbauer C; Wira CR
PLoS One; 2010 Jun; 5(6):e11366. PubMed ID: 20614007
[TBL] [Abstract][Full Text] [Related]
55. Quantitation of human immunodeficiency virus type 1 RNA loads in cervicovaginal secretions in pregnant women and relationship between viral loads in the genital tract and blood.
García-Bujalance S; Ruiz G; De Guevara CL; Peña JM; Bates I; Vázquez JJ; Gutiérrez A
Eur J Clin Microbiol Infect Dis; 2004 Feb; 23(2):111-5. PubMed ID: 14735402
[TBL] [Abstract][Full Text] [Related]
56. Systemic Immune Activation and HIV Shedding in the Female Genital Tract.
Spencer LY; Christiansen S; Wang CH; Mack WJ; Young M; Strickler HD; Anastos K; Minkoff H; Cohen M; Geenblatt RM; Karim R; Operskalski E; Frederick T; Homans JD; Landay A; Kovacs A
J Acquir Immune Defic Syndr; 2016 Feb; 71(2):155-62. PubMed ID: 26334738
[TBL] [Abstract][Full Text] [Related]
57. Presence of cell-free human immunodeficiency virus in cervicovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women.
Rasheed S; Li Z; Xu D; Kovacs A
Am J Obstet Gynecol; 1996 Jul; 175(1):122-9. PubMed ID: 8694037
[TBL] [Abstract][Full Text] [Related]
58. Independent levels of cell-free and cell-associated human immunodeficiency virus-1 in genital-tract secretions of clinically asymptomatic, treatment-naive African women.
Andréoletti L; Chomont N; Grésenguet G; Matta M; de Dieu Longo J; Carreno MP; Si-Mohamed A; Legoff J; Kazatchkine MD; Bélec L
J Infect Dis; 2003 Aug; 188(4):549-54. PubMed ID: 12898442
[TBL] [Abstract][Full Text] [Related]
59. Selection of drug-resistant variants in the female genital tract of human immunodeficiency virus type 1-infected women receiving antiretroviral therapy.
Si-Mohamed A; Kazatchkine MD; Heard I; Goujon C; Prazuck T; Aymard G; Cessot G; Kuo YH; Bernard MC; Diquet B; Malkin JE; Gutmann L; Bélec L
J Infect Dis; 2000 Jul; 182(1):112-22. PubMed ID: 10882588
[TBL] [Abstract][Full Text] [Related]
60. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission.
Panther LA; Tucker L; Xu C; Tuomala RE; Mullins JI; Anderson DJ
J Infect Dis; 2000 Feb; 181(2):555-63. PubMed ID: 10669339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
